“I’m already seventy—why bother with surgery?” The elderly lady set her imaging films down on the desk. The pituitary adenoma, measuring 16 mm (moderately large), was discovered incidentally during a routine physical checkup. She had no vision loss, headaches, or any other discomfort.

She repeated the same line, placing her scans on the table. The 16 mm moderately large pituitary adenoma was found by chance in a health screening, with no accompanying vision impairment, headaches or physical complaints. She had been referred to neurosurgery for consultation but viewed the visit as a mere formality. Her husband sat beside her, sharing the same dismissive expression.

The doctor mounted the films on a lightbox and examined them carefully before asking, “How long have you been taking your anticoagulant medication?” The lady replied that she had been on the drugs for three years following cardiac stent implantation. The doctor responded, “Then we need to discuss this tumor seriously. Your anticoagulant regimen puts you in a different clinical scenario from most other patients.” The woman looked stunned.

A pituitary adenoma measuring 16 mm develops an extensive internal blood vessel network. Anticoagulants inhibit blood clotting, which benefits cardiac health yet significantly elevates the risk of intratumoral hemorrhage. The combination of these two factors places the estimated clinical risk of bleeding at approximately 20%. This figure is not an exact value but a standard clinical range. When the lady asked about the consequences of hemorrhage, the doctor explained that mild bleeding could create a hematoma compressing the optic chiasm, potentially causing sudden permanent blindness. Severe bleeding may trigger pituitary apoplexy complicated by acute adrenal crisis, marked by plummeting blood pressure and electrolyte disturbances—complications that a 70-year-old body may struggle to withstand. The doctor recounted similar cases from his outpatient practice: patients on long-term anticoagulants with comparably sized asymptomatic pituitary tumors who opted for watchful waiting, only to suffer intratumoral hemorrhage resulting in irreversible vision loss. Her husband’s face paled, and he asked about the risks of surgical intervention. The doctor then outlined the transnasal surgical plan.

The procedure avoids craniotomy and adopts an endoscopic transsphenoidal approach through the nasal cavity, requiring no scalp incision or bone flap elevation. Uncomplicated cases allow discharge within six to seven days postoperatively, followed by a return to regular daily life. Surgery is not without risks for septuagenarians; anesthesia hazards and postoperative electrolyte fluctuations cannot be ruled out entirely. Even so, the surgical risk profile is far more predictable than the 20% hemorrhage risk associated with prolonged anticoagulant use under surveillance. The doctor noted that he had treated numerous comparable patients in their early seventies on anticoagulants with moderately sized pituitary adenomas who hesitated over surgery. His clinical experience underscores one principle: if the patient’s physical condition can tolerate the operation, early intervention is vastly preferable to delayed treatment. Delaying surgery until the tumor enlarges or bleeds (after vision damage sets in) means the same surgical procedure will no longer restore lost eyesight. While the patient survives the operation, they will face decades of permanent visual field defects—a clinical outcome the doctor had witnessed repeatedly and hoped to spare this patient from enduring.

The lady asked how her anticoagulant medication would be managed. The doctor explained that the drugs would be paused preoperatively under a joint protocol formulated by anesthesiology and cardiology teams, then reinitiated postoperatively based on individual bleeding risk. Cardiologists routinely manage this medication adjustment process, so excessive worry was unnecessary.

The woman exchanged glances with her husband and said she would return home to discuss the matter with their children. The doctor advised her to fully explain the hemorrhage risk linked to anticoagulants, involve all family members in the conversation, and reach a collective decision before proceeding.